Dopamine News and Research

Latest Dopamine News and Research

High dopamine transporter levels not linked to attention-deficit hyperactivity disorder

Results from a brain-imaging study conducted at the U.S. Department of Energy's Brookhaven National Laboratory in collaboration with Mount Sinai School of Medicine in New York indicate that levels of a brain protein proposed as a diagnostic marker for attention-deficit hyperactivity disorder (ADHD) are not positively correlated with the disease.

2 Dec 2006

UIC study evaluates two medications for ADHD

University of Illinois at Chicago researchers are comparing two drugs commonly used to treat attention deficit hyperactivity disorder to determine if genetic factors predict which children will respond to either or both drugs.

7 Nov 2006

Experts say "schizophrenia label" a harmful concept which should be dropped

British mental health experts say the term schizophrenia should abandoned as it has little scientific validity, and is imprecise and stigmatizing.

From The University of Manchester 10 Oct 2006

Nicotine shows potential medical benefits

Nicotine may improve the symptoms of depression in people who do not smoke, Duke University Medical Center scientists have discovered.

12 Sep 2006

Boston Life Sciences announces issuance of U.S. patent for methods to diagnose ADHD

Boston Life Sciences has announced that the U.S. Patent and Trademark Office has issued a patent to the President and Fellows of Harvard College, the General Hospital Corporation and Organix that covers methods of diagnosing and monitoring attention deficit hyperactivity disorder (ADHD) by assessing the level of dopamine transporter (DAT) in at least one region of a patient's central nervous system.

14 Aug 2006

Nicotine shows promise as treatment against Parkinson's disease

New research suggests that nicotine treatment protects against the same type of brain damage that occurs in Parkinson's disease.

7 Aug 2006

Methamphetamine increases production of protein that promotes the spread of the HIV-1 virus in infected drug users

Researchers at the University at Buffalo have presented the first evidence that the addictive drug methamphetamine, or meth, also commonly known as "speed" or "crystal," increases production of a docking protein that promotes the spread of the HIV-1 virus in infected users.

4 Aug 2006

fMRI shows "gambling" structures in the brain

From gamblers playing blackjack to investors picking stocks, humans make a wide range of decisions that require gauging risk versus reward.

2 Aug 2006

Novelty aids learning

Exposure to new experiences improves memory, according to research by UCL (University College London) psychologists and medical doctors that could hold major implications for the treatment of memory problems.

2 Aug 2006

New genetic model for Parkinson's disease

Researchers at the Karolinska Institute in Sweden are homing in on mechanisms that may explain one set of causes for Parkinson's disease.

1 Aug 2006

Naltrexone may increase the urge to drink

Naltrexone (NTX) is able to reduce drinking and craving among many alcoholics and heavy drinkers, but not all of them.

25 Jul 2006

Digital magnetofluidics holds hope for better medicine

Critical advances in medicine and environmental protection promise to emerge from a new method for biochemical analysis of fluids developed by an international science team led in part by Arizona State University researchers.

21 Jul 2006

Human hair follicles found to be a new source of adult stem cells

Researchers at the University of Pennsylvania School of Medicine have isolated a new source of adult stem cells that appear to have the potential to differentiate into several cell types.

12 Jul 2006

Dopamine drug leads to new neurons and recovery of function in Parkinson's

In preliminary results, researchers have shown that a drug which mimics the effects of the nerve-signaling chemical dopamine causes new neurons to develop in the part of the brain where cells are lost in Parkinson's disease (PD).

5 Jul 2006

New anti-smoking drug Varenicline (Chantix) promotes longer-lasting abstinence

Scientists have found that a new anti-smoking drug may be more effective than drugs currently in use to help smokers kick the habit and it has the added advantage of promoting longer-lasting abstinence.

5 Jul 2006

Varenicline effective in helping smokers quit

The drug varenicline shows effectiveness in helping smokers quit and abstain from smoking when compared to placebo and the smoking cessation medication bupropion.

4 Jul 2006

Dopamine drug may lead to new ways of treating Parkinson's and other neurodegenerative diseases

Researchers have shown that a drug which mimics the effects of the nerve-signaling chemical dopamine causes new neurons to develop in the part of the brain where cells are lost in Parkinson's disease

4 Jul 2006

Link established between Parkinson's and pesticides

Researchers in the U.S. say they have found evidence that exposure to pesticides may be linked to the development of Parkinson's disease (PD).

27 Jun 2006

Study shows how ADHD drugs Adderall, Ritalin and Dexedrine work in brain

Although millions depend on medications such as Ritalin to quell symptoms of attention deficit hyperactivity disorder (ADHD), scientists have struggled to pinpoint how the drugs work in the brain.

27 Jun 2006